Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis

Author:

Salonen JohannaORCID,Kreus Mervi,Lehtonen Siri,Vähänikkilä Hannu,Purokivi Minna,Kaarteenaho Riitta

Abstract

Abstract Mast cells (MCs) are known to be involved in the pathogenesis of idiopathic pulmonary fibrosis (IPF), although their role in acute exacerbations of IPF has not been investigated. The aims of the study were to evaluate the numbers of MCs in fibrotic and non-fibrotic areas of lung tissue specimens of idiopathic pulmonary fibrosis (IPF) patients with or without an acute exacerbation of IPF, and to correlate the MC density with clinical parameters. MCs of IPF patients were quantified from surgical lung biopsy (SLB) specimens (n = 47) and lung tissue specimens taken at autopsy (n = 7). MC density was higher in the fibrotic areas of lung tissue compared with spared alveolar areas or in controls. Female gender, low diffusion capacity for carbon monoxide, diffuse alveolar damage, and smoking were associated with a low MC density. MC densities of fibrotic areas had declined significantly in five subjects in whom both SLB in the stable phase and autopsy after an acute exacerbation of IPF had been performed. There were no correlations of MC densities with survival time or future acute exacerbations. The MC density in fibrotic areas was associated with several clinical parameters. An acute exacerbation of IPF was associated with a significant decline in MC counts. Further investigations will be needed to clarify the role of these cells in IPF and in the pathogenesis of acute exacerbation as this may help to identify some potential targets for medical treatment for this serious disease.

Funder

Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö

Hengityssairauksien Tutkimussäätiö

Jalmari ja Rauha Ahokkaan Säätiö

Research Foundation of North Finland

Tampereen Tuberkuloosisäätiö

Väinö ja Laina Kiven Säätiö

University of Oulu including Oulu University Hospital

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Collard, Harold R., Christopher J. Ryerson, Tamera J. Corte, Gisli Jenkins, Yasuhiro Kondoh, David J. Lederer, Joyce S. Lee, Toby M. Maher, Athol U. Wells, Katerina M. Antoniou, Juergen Behr, Kevin K. Brown, Vincent Cottin, Kevin R. Flaherty, Junya Fukuoka, David M. Hansell, Takeshi Johkoh, Naftali Kaminski, Dong Soon Kim, Martin Kolb, David A. Lynch, Jeffrey L. Myers, Ganesh Raghu, Luca Richeldi, Hiroyuki Taniguchi, and Fernando J. Martinez. 2016. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. American Journal of Respiratory and Critical Care Medicine 194: 265–275. https://doi.org/10.1164/rccm.201604-0801CI.

2. Raghu, Ganesh, Martine Remy-Jardin, Jeffrey L. Myers, Luca Richeldi, Christopher J. Ryerson, David J. Lederer, Juergen Behr, Vincent Cottin, Sonye K. Danoff, Ferran Morell, Kevin R. Flaherty, Athol Wells, Fernando J. Martinez, Arata Azuma, Thomas J. Bice, Demosthenes Bouros, Kevin K. Brown, Harold R. Collard, Abhijit Duggal, Liam Galvin, Yoshikazu Inoue, R. Gisli Jenkins, Takeshi Johkoh, Ella A. Kazerooni, Masanori Kitaichi, Shandra L. Knight, George Mansour, Andrew G. Nicholson, Sudhakar N. Pipavath, Ivette Buendía-Roldán, Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson, American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. 2018. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine 198: e44–e68. https://doi.org/10.1164/rccm.201807-1255ST.

3. Heukels, P., C.C. Moor, J.H. von der Thüsen, M.S. Wijsenbeek, and M. Kool. 2019. Inflammation and immunity in IPF pathogenesis and treatment. Respiratory Medicine 147: 79–91. https://doi.org/10.1016/j.rmed.2018.12.015.

4. Mekori, Y.A. 2004. The mastocyte: The “other” inflammatory cell in immunopathogenesis. The Journal of Allergy and Clinical Immunology 114: 52–57. https://doi.org/10.1016/j.jaci.2004.04.015.

5. Erjefalt, Jonas S. 2014. Mast cells in human airways: The culprit? European Respiratory Review : An Official Journal of the European Respiratory Society 23: 299–307. https://doi.org/10.1183/09059180.00005014.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3